Stockreport

Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests – for Colorectal Cancer and for Breast Cance...

Genetic Technologies Ltd - American Depositary Shares  (GENE) 
US:NASDAQ Investor Relations: gtgcorporate.com/investor-centre
PDF MELBOURNE, Australia, May 10, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ Ticker: GENE) is delighted to announce that following substantial [Read more]